Limb Girdle Muscular Dystrophy (LGMD) Type 2I research hub

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of BBP-418 (Ribitol) in Participants with Limb-Girdle Muscular Dystrophy 2I/R9 (LGMD2I/R9)

This study looks at a medicine called Ribitol (BBP-418) for adults with limb-girdle muscular dystrophy type 2I. Researchers want to see if taking Ribitol long-term is safe and helps people keep their muscle strength, walking ability, and lung function over time.